☰

Ganesamoorthy Subbanagounder - Publications

Affiliations: 
Chemistry Case Western Reserve University, Cleveland Heights, OH, United States 
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. The Journal of Experimental Medicine. 200: 1359-70. PMID 15583011 DOI: 10.1084/Jem.20031763  0.503
2003 Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1384-90. PMID 12805072 DOI: 10.1161/01.Atv.0000081215.45714.71  0.377
2003 Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL, Lucas RM, Nakai J, Smart EJ, Vora DK, Berliner JA. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1197-203. PMID 12775576 DOI: 10.1161/01.Atv.0000079340.80744.B8  0.363
2003 Jung ME, Kers A, Subbanagounder G, Berliner JA. Studies towards the total synthesis of an epoxy isoprostane phospholipid, a potent activator of endothelial cells. Chemical Communications (Cambridge, England). 196-7. PMID 12585388 DOI: 10.1039/B209892J  0.316
2002 Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vascular Pharmacology. 38: 201-9. PMID 12449016 DOI: 10.1016/S1537-1891(02)00170-2  0.647
2002 Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, Berliner JA. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. The Journal of Biological Chemistry. 277: 7271-81. PMID 11751881 DOI: 10.1074/Jbc.M107602200  0.302
2001 Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends in Cardiovascular Medicine. 11: 142-7. PMID 11686004 DOI: 10.1016/S1050-1738(01)00098-6  0.481
2001 Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. Journal of Lipid Research. 42: 1308-17. PMID 11483633  0.353
2001 Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 481-8. PMID 11304461 DOI: 10.1161/01.Atv.21.4.481  0.487
2000 Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 2248-54. PMID 11031211 DOI: 10.1161/01.Atv.20.10.2248  0.428
2000 Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circulation Research. 87: 516-21. PMID 10988245 DOI: 10.1161/01.Res.87.6.516  0.44
2000 Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. Journal of Lipid Research. 41: 1481-94. PMID 10974056  0.348
2000 Subbanagounder G, Watson AD, Berliner JA. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radical Biology & Medicine. 28: 1751-61. PMID 10946217 DOI: 10.1016/S0891-5849(00)00233-1  0.503
2000 Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, Lusis AJ. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis Journal of Biological Chemistry. 275: 17527-17535. PMID 10748217 DOI: 10.1074/Jbc.M910376199  0.398
1999 Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, Vora DK. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils Proceedings of the National Academy of Sciences of the United States of America. 96: 12010-12015. PMID 10518567 DOI: 10.1073/Pnas.96.21.12010  0.443
1999 Watson AD, Subbanagounder G, Welsbie DS, Faull KF, Navab M, Jung ME, Fogelman AM, Berliner JA. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. The Journal of Biological Chemistry. 274: 24787-98. PMID 10455151 DOI: 10.1074/Jbc.274.35.24787  0.529
1999 Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: In vitro and in vivo inhibition by WEB 2086 Circulation Research. 85: 311-318. PMID 10455059 DOI: 10.1161/01.Res.85.4.311  0.454
1999 Salomon RG, Sha W, Brame C, Kaur K, Subbanagounder G, O'Neil J, Hoff HF, Roberts LJ. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. The Journal of Biological Chemistry. 274: 20271-80. PMID 10400646 DOI: 10.1074/Jbc.274.29.20271  0.757
1999 Hörkkö S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. The Journal of Clinical Investigation. 103: 117-28. PMID 9884341 DOI: 10.1172/Jci4533  0.548
1997 Salomon RG, Subbanagounder G, Singh U, O'Neil J, Hoff HF. Oxidation of low-density lipoproteins produces levuglandin-protein adducts Chemical Research in Toxicology. 10: 750-759. PMID 9250408 DOI: 10.1021/Tx970016B  0.761
1997 Salomon RG, Subbanagounder G, O'Neil J, Kaur K, Smith MA, Hoff HF, Perry G, Monnier VM. Levuglandin E2 - Protein adducts in human plasma and vasculature Chemical Research in Toxicology. 10: 536-545. PMID 9168251 DOI: 10.1021/Tx960157Y  0.712
1997 Watson AD, Leitinger N, Navab M, Faull KF, Hörkkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. The Journal of Biological Chemistry. 272: 13597-607. PMID 9153208 DOI: 10.1074/Jbc.272.21.13597  0.696
1997 Hoppe G, Subbanagounder G, O'Neil J, Salomon RG, Hoff HF. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid Biochimica Et Biophysica Acta - Lipids and Lipid Metabolism. 1344: 1-5. PMID 9022751 DOI: 10.1016/S0005-2760(96)00160-9  0.677
1997 Subbanagounder G, Salomon RG, Murthi KK, Brame C, Jackson Roberts L. Total Synthesis of Iso[4]-levuglandin E2 Journal of Organic Chemistry. 62: 7658-7666. DOI: 10.1021/Jo981929T  0.566
1996 Sayre LM, Sha W, Xu G, Kaur K, Nadkarni D, Subbanagounder G, Salomon RG. Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chemical Research in Toxicology. 9: 1194-201. PMID 8902276 DOI: 10.1021/Tx960094J  0.721
1995 DiFranco E, Subbanagounder G, Kim S, Murthi K, Taneda S, Monnier VM, Salomon RG. Formation and stability of pyrrole adducts in the reaction of Levuglandin E2 with proteins Chemical Research in Toxicology. 8: 61-67. PMID 7703368 DOI: 10.1021/Tx00043A008  0.616
Show low-probability matches.